TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may enhance the pathogenesis of the disease.
Immunobiology
; 228(5): 152725, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37562277
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leishmania donovani
/
Leishmania
/
Leishmaniasis, Visceral
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Immunobiology
Year:
2023
Document type:
Article
Affiliation country:
China